Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.8B | 11.8B | 11.1B | 11.0B |
Cost of revenue | 9.5B | 9.3B | 8.8B | 8.6B |
Gross profit | 2.3B | 2.5B | 2.3B | 2.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 437.1M | 483.7M | 368.2M | 509.2M |
Operating income | 1.0B | 1.1B | 1.1B | 1.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 81M | 92.6M | 144.2M | 91.3M |
Other income expense | — | — | — | — |
Pretax income | 789.5M | 1.1B | 1.4B | 1.0B |
Tax provision | 186.7M | 214.8M | 303.1M | 217.2M |
Net income | 602.8M | 854.7M | 1.1B | 811.6M |
Basic EPS | — | 13.1 | 16.1 | 12.5 |
Diluted EPS | — | 13.1 | 16.1 | 12.5 |
Basic average shares | — | 63.0M | 62.8M | 62.8M |
Diluted average shares | — | 63.0M | 62.8M | 62.8M |
EBITDA | 1.3B | 1.4B | 1.7B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -37M | -29.9M | -57.6M | -26.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |